Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/37423| Title: | Impending central retinal vein occlusion and cilioretinal artery occlusion in a pediatric case with MTHFR A1298C heterozygous polymorphism and ANA positivity | Other Titles: | MTHFR A1298C Heterozigot Polimorfizmli bir Pediatrik Olguda Santral Retinal Ven Oklüzyonu Tehdidi ve Silioretinal Arter Oklüzyonu | Authors: | Kasikci, S.A. Çetin, Ebru Nevin Parca, O. Pekel, Gökhan Zeybek, S. Yüksel, Selçuk |
Keywords: | Cilioretinal artery occlusion Impending central retinal vein occlusion MTHFR A1298C heterozygous polymorphism Pediatric case antinuclear antibody brimonidine methylenetetrahydrofolate reductase (NADPH2) timolol maleate adolescent Article best corrected visual acuity case report central retina vein occlusion ciliary artery clinical article controlled study eye edema follow up genetic analysis genetic polymorphism heterozygote human intraocular pressure male optic disk retina artery occlusion retina fluorescein angiography retina hemorrhage topical treatment vitreous hemorrhage |
Publisher: | Gazi Eye Foundation | Abstract: | A 13-years old boy presented with impending central retinal venous occlusion followed by ciliary artery occlusion and vitreous hemorrhage. A detailed systemic investigation revealed ANA positivity and heterozygote polymorphism in MTHFR A1298C.Visual acuity immediately improved after starting topical anti-glaucomatous treatment for impending central retinal venous occlusion and remained at 1.0 during the 6-month follow-up. © 2019 Gazi Eye Foundation. All rights reserved. | URI: | https://hdl.handle.net/11499/37423 | ISSN: | 1300-1256 |
| Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.